Benzinga · Sep 18, 2026
Why Is Tempus AI Stock Falling Friday?
Tempus AI stock pulled back Friday but stays firmly above key moving averages. Is the TEM rally still intact? Read more.
NASDAQ · TEM
Healthcare · Medical - Healthcare Information Services
$77.84
Down-$2.52 (-3.14%)
Updated Sep 20, 2026, 12:37 PM
SID Score
6.7/10
Composite research score
Smart Money
58/100
Neutral
Price performance
1M range · 19 trading sessions · Daily adjusted prices
TEM closed at $77.84 after 19 trading sessions, up 17.64% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 18, 2026 | $81.40 | $81.83 | $75.99 | $77.84 | 9.32M |
| Sep 17, 2026 | $72.70 | $81.28 | $72.61 | $80.36 | 16.88M |
| Sep 16, 2026 | $68.79 | $71.48 | $68.4201 | $69.97 | 7.59M |
| Sep 15, 2026 | $61.905 | $68.939 | $61.88 | $68.85 | 8.25M |
| Sep 14, 2026 | $57.725 | $62.81 | $57.72 | $62.21 | 4.72M |
| Sep 11, 2026 | $59.47 | $60.38 | $58.48 | $59.01 | 3.69M |
| Sep 10, 2026 | $59.87 | $61.11 | $58.02 | $58.74 | 5.5M |
| Sep 9, 2026 | $63.42 | $64.91 | $60.93 | $61.28 | 6.62M |
| Sep 8, 2026 | $64.04 | $65.79 | $63.21 | $64.29 | 5.2M |
| Sep 4, 2026 | $64.76 | $66.30 | $63.11 | $64.62 | 4.57M |
| Sep 3, 2026 | $63.00 | $64.8131 | $61.19 | $64.66 | 4.92M |
| Sep 2, 2026 | $63.15 | $67.0999 | $60.06 | $61.94 | 5.79M |
| Sep 1, 2026 | $65.64 | $65.79 | $61.22 | $62.27 | 6.24M |
| Aug 31, 2026 | $62.365 | $64.55 | $60.5804 | $63.05 | 7.18M |
| Aug 28, 2026 | $69.045 | $70.8999 | $63.77 | $64.04 | 8.77M |
| Aug 27, 2026 | $68.65 | $71.89 | $67.80 | $70.69 | 6.59M |
| Aug 26, 2026 | $67.48 | $70.2174 | $67.30 | $68.48 | 5.23M |
| Aug 25, 2026 | $66.58 | $70.79 | $63.6101 | $68.73 | 8.88M |
| Aug 24, 2026 | $70.075 | $72.02 | $65.93 | $66.17 | 11.93M |
The latest Smart Investors Daily articles mentioning TEM.
TEM research
Company profile and research snapshot.
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 11, 2026 | HC Wainwright & Co. | Buy | — |
| Sep 9, 2026 | UBS | Neutral | — |
| Sep 8, 2026 | Rothschild & Co | Neutral | — |
| Sep 8, 2026 | Roth Capital | Neutral | — |
| Sep 2, 2026 | Cantor Fitzgerald | Overweight | — |
No generated briefing is available yet.
Benzinga · Sep 18, 2026
Tempus AI stock pulled back Friday but stays firmly above key moving averages. Is the TEM rally still intact? Read more.
Yahoo · Sep 18, 2026
Tempus (TEM) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Yahoo · Sep 18, 2026
NVIDIA, Advanced Micro Devices, Tempus, Moderna, Super Micro Computer and Aya Gold & Silver have been highlighted in this Investment Ideas article.
Yahoo · Sep 17, 2026
While macroeconomic headwinds, geopolitical energy shocks, and relentless media fear-mongering might suggest a market correction is overdue, the resilience of stock price action tells a different story.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning TEM.